Squamous tissue lymphocytes in the esophagus of controls and patients with reflux esophagitis and barrett's esophagus are characterized by a non-inflammatory phenotype

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Lind, Alexandra ^a   Koenderman, Leo ^a   Kusters, Johannes G ^a   Siersema, Peter D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD103 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL MARKER; GRANZYME B; NATURAL KILLER CELL RECEPTOR NKG2A; DIFFERENTIATION ANTIGEN;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ESOPHAGUS BIOPSY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; INTESTINE METAPLASIA; LYMPHOCYTE COUNT; MALE; PHENOTYPE; REFLUX ESOPHAGITIS; SQUAMOUS EPITHELIUM; T LYMPHOCYTE; TISSUE CHARACTERIZATION; TISSUE CULTURE; AGED; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; EPITHELIUM CELL; ESOPHAGITIS; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; IMMUNOLOGY; MIDDLE AGED; NATURAL KILLER CELL; PATHOLOGY;

ADULT; AGED; ANTIGENS, DIFFERENTIATION; BARRETT ESOPHAGUS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EPITHELIAL CELLS; ESOPHAGITIS; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED;

EID: 84930576683     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106261     Document Type: Article

References (49)

1. Souza RF (2010) The role of acid and bile reflux in oesophagitis and Barrett's metaplasia. Biochem Soc Trans 38: 348-352.
2. Dickman R, Bautista JM, Wong WM, Bhatt R, Beeler JN, et al. (2006) Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups. Am J Gastroenterol 101: 2463-2469. (Pubitemid 44665239)
3. Gilani N, Gerkin RD, Ramirez FC, Hakim S, Randolph AC (2008) Prevalence of Barrett's esophagus in patients with moderate to severe erosive esophagitis. World J Gastroenterol 14: 3518-3522.
4. Oberg S, Johansson J, Wenner J, Walther B (2002) Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann Surg 235: 338-345. (Pubitemid 34183884)
5. Franchimont D, Covas A, Brasseur C, Laethem JL, El-Nakadi I, et al. (2003) Newly developed Barrett's esophagus after subtotal esophagectomy. Endoscopy 35: 850-853. (Pubitemid 37254220)
6. Shan J, Oshima T, Farre R, Fukui H, Watari J, et al. (2014) IL-4 induces columnar like differentiation of esophageal squamous epithelium through JAK/PI3K pathway: possible role in pathogenesis of Barrett's esophagus. Am J Physiol Gastrointest Liver Physiol. ajpgi.00386.2013 [pii];10.1152/ajpgi.00386.2013 [doi].
7. Picardo SL, Maher SG, O'Sullivan JN, Reynolds JV (2012) Barrett's to oesophageal cancer sequence: a model of inflammatory-driven upper gastrointestinal cancer. Dig Surg 29: 251-260. 000341498 [pii];10.1159/000341498 [doi].
8. Colleypriest BJ, Ward SG, Tosh D (2009) How does inflammation cause Barrett's metaplasia? Curr Opin Pharmacol 9: 721-726.
9. Poehlmann A, Kuester D, Malfertheiner P, Guenther T, Roessner A (2012) Inflammation and Barrett's carcinogenesis. Pathol Res Pract 208: 269-280. S0344-0338(12)00098-2 [pii];10.1016/j.prp.2012.03.007 [doi].
10. Fitzgerald RC, Onwuegbusi BA, Bajaj-Elliott M, Saeed IT, Burnham WR, et al. (2002) Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 50: 451-459. (Pubitemid 34638860)
11. Fitzgerald RC, Abdalla S, Onwuegbusi BA, Sirieix P, Saeed IT, et al. (2002) Inflammatory gradient in Barrett's oesophagus: implications for disease complications. Gut 51: 316-322.
12. Huo X, Zhang HY, Zhang XI, Lynch JP, Strauch ED, et al. (2010) Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus. Gastroenterology 139: 194-203.
13. Souza RF, Huo X, Mittal V, Schuler CM, Carmack SW, et al. (2009) Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 137: 1776-1784.
14. Zhang F, Altorki NK, Wu YC, Soslow RA, Subbaramaiah K, et al. (2001) Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology 121: 1391-1399. (Pubitemid 33140456)
15. Souza RF, Shewmake KL, Shen Y, Ramirez RD, Bullock JS, et al. (2005) Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus. Am J - Gastroenterol 100: 551-559. (Pubitemid 40487552)
16. Zhang HY, Zhang X, Chen X, Thomas D, Hormi-Carver K, et al. (2008) Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus. Am J Physiol Gastrointest Liver Physiol 295: G470-G478.
17. Ali I, Rafiee P, Hogan WJ, Jacob HJ, Komorowski RA, et al. (2006) Dickkopf homologs in squamous mucosa of esophagitis patients are overexpressed compared with Barrett's patients and healthy controls. Am J Gastroenterol 101: 1437-1448. (Pubitemid 43980614)
18. Teng XJ, Liu R, Li XJ, He JF, Xiao SS (2013) Increased expression of endothelin-1 and endothelin receptor A in reflux esophagitis and Barrett's esophagus. Dis Esophagus 26: 668-673. 10.1111/dote.12031 [doi].
19. Yang L, Francois F, Pei Z (2012) Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus. Clin Cancer Res 18: 2138-2144. 1078-0432.CCR-11-0934 [pii];10.1158/1078-0432.CCR-11-0934 [doi].
20. Kong J, Crissey MA, Funakoshi S, Kreindler JL, Lynch JP (2011) Ectopic Cdx2 expression in murine esophagus models an intermediate stage in the emergence of Barrett's esophagus. PLoS One 6: e18280.
21. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, et al. (1999) Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 45: 172-180. (Pubitemid 29333764)
22. Johansson J, Hakansson HO, Mellblom L, Kempas A, Johansson KE, et al. (2005) Prevalence of precancerous and other metaplasia in the distal oesophagus and gastro-oesophageal junction. Scand J Gastroenterol 40: 893-902. (Pubitemid 41117013)
23. Clark RA, Chong BF, Mirchandani N, Yamanaka K, Murphy GF, et al. (2006) A novel method for the isolation of skin resident T cells from normal and diseased human skin. J Invest Dermatol 126: 1059-1070.
24. Piet B, de Bree GJ, Smids-Dierdorp BS, van der Loos CM, Remmerswaal EB, et al. (2011) CD8 T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung. J Clin Invest 121: 2254-2263.
25. Anz D, Mueller W, Golic M, Kunz WG, Rapp M, et al. (2011) CD103 is a hallmark of tumor-infiltrating regulatory T cells. Int J Cancer.
26. Hirosako S, Goto E, Tsumori K, Fujii K, Hirata N, et al. (2010) CD8 and CD103 are highly expressed in asthmatic bronchial intraepithelial lymphocytes. Int Arch Allergy Immunol 153: 157-165.
27. Koch SD, Uss E, van Lier RA, ten B I (2008) Alloantigen-induced regulatory CD8+CD103+ T cells. Hum Immunol 69: 737-744.
28. Zingg U, Montani M, Frey DM, Dirnhofer S, Esterman AJ, et al. (2010) Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus. Eur J Surg Oncol 36: 670-677.
29. Afonina IS, Cullen SP, Martin SJ (2010) Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B. Immunol Rev 235: 105-116.
30. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, et al. (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795-799. (Pubitemid 28099678)
31. Ikeda H, Lethe B, Lehmann F, van Baren N, Baurain JF, et al. (1997) Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6: 199-208. (Pubitemid 27145564)
32. Mingari MC, Ponte M, Vitale C, Bellomo R, Moretta L (2000) Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T-cell activation and function. Hum Immunol 61: 44-50. (Pubitemid 30058766)
33. Fuentebella J, Patel A, Nguyen T, Sanjanwala B, Berquist W, et al. (2010) Increased number of regulatory T cells in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 51: 283-289.
34. Moons LM, Kusters JG, Bultman E, Kuipers EJ, van Dekken H, et al. (2005) Barrett's oesophagus is characterized by a predominantly humoral inflammatory response. J Pathol 207: 269-276. (Pubitemid 41556450)
35. Carmack SW, Lash RH, Gulizia JM, Genta RM (2009) Lymphocytic disorders of the gastrointestinal tract: a review for the practicing pathologist. Adv Anat Pathol 16: 290-306.
36. Resnick MB, Finkelstein Y, Weissler A, Levy J, Yakirevich E (1999) Assessment and diagnostic utility of the cytotoxic T-lymphocyte phenotype using the specific markers granzyme-B and TIA-1 in esophageal mucosal biopsies. Hum Pathol 30: 397-402. (Pubitemid 29177818)
37. Kohata Y, Fujiwara Y, Machida H, Okazaki H, Yamagami H, et al. (2011) Role of Th-2 cytokines in the development of Barrett's esophagus in rats. J Gastroenterol 46: 883-893.
38. Lind A, Siersema PD, Kusters JG, Van der Linden JA, Knol EF, et al. (2012) The immune cell composition in Barrett's metaplastic tissue resembles that in normal duodenal tissue. PLoS One 7: e33899. 10.1371/journal.pone.0033899 [doi];PONE-D-11-25288 [pii].
39. Yu YH, Han DS, Choi EY, Park HS, Jeong JY, et al. (2012) Is use of PPIs related to increased intraepithelial lymphocytes in the colon? Dig Dis Sci 57: 2669-2674. 10.1007/s10620-012-2315-0 [doi].
40. Kilshaw PJ (1999) Alpha E beta 7. Mol Pathol 52: 203-207.
41. El-Asady R, Yuan R, Liu K, Wang D, Gress RE, et al. (2005) TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease. J Exp Med 201: 1647-1657. (Pubitemid 40721008)
42. Bierie B, Moses HL (2010) Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev 21: 49-59. S1359-6101(09)00115-4 [pii];10.1016/j.cytogfr.2009.11.008 [doi].
43. Cepek KL, Shaw SK, Parker CM, Russell GJ, Morrow JS, et al. (1994) Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 372: 190-193.
44. Uss E, Rowshani AT, Hooibrink B, Lardy NM, van Lier RA, et al. (2006) CD103 is a marker for alloantigen-induced regulatory CD8+ T cells. J Immunol 177: 2775-2783. (Pubitemid 44277792)
45. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, varez-Mon M, et al. (1986) Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163: 1037-1050. (Pubitemid 16000407)
46. Hodge SJ, Hodge GL, Reynolds PN, Scicchitano R, Holmes M (2003) Increased production of TGF-beta and apoptosis of T lymphocytes isolated from peripheral blood in COPD. Am J Physiol Lung Cell Mol Physiol 285: L492-L499. (Pubitemid 36909467)
47. Worthington JJ, Czajkowska BI, Melton AC, Travis MA (2011) Intestinal dendritic cells specialize to activate transforming growth factor-beta and induce Foxp3+ regulatory T cells via integrin alphavbeta8. Gastroenterology 141: 1802-1812.
48. Mendelson J, Song S, Li Y, Maru DM, Mishra B, et al. (2011) Dysfunctional transforming growth factor-beta signaling with constitutively active Notch signaling in Barrett's esophageal adenocarcinoma. Cancer 117: 3691-3702.
49. Speiser DE, Pittet MJ, Valmori D, Dunbar R, Rimoldi D, et al. (1999) In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J Exp Med 190: 775-782. (Pubitemid 29451623)